These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 17947967)
81. Pretravel health preparation among US residents traveling to India to VFRs: importance of ethnicity in defining VFRs. Baggett HC; Graham S; Kozarsky PE; Gallagher N; Blumensaadt S; Bateman J; Edelson PJ; Arguin PM; Steele S; Russell M; Reed C J Travel Med; 2009; 16(2):112-8. PubMed ID: 19335811 [TBL] [Abstract][Full Text] [Related]
82. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857 [TBL] [Abstract][Full Text] [Related]
83. Hepatitis A vaccination. Thiel TK Am Fam Physician; 1998 Apr; 57(7):1500. PubMed ID: 9556642 [No Abstract] [Full Text] [Related]
84. Immune globulins for protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services, Atlanta, Georgia. Ann Intern Med; 1982 Feb; 96(2):193-7. PubMed ID: 6277217 [No Abstract] [Full Text] [Related]
85. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060 [TBL] [Abstract][Full Text] [Related]
86. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):312. PubMed ID: 19343012 [TBL] [Abstract][Full Text] [Related]
87. Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep; 2000 Jul; 26():12-8. PubMed ID: 10927838 [No Abstract] [Full Text] [Related]
88. Statement on hepatitis vaccines for travellers. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT) Can Commun Dis Rep; 2008 Jul; 34(ACS-2):1-24. PubMed ID: 18802989 [No Abstract] [Full Text] [Related]
89. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. ; MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):343-4. PubMed ID: 18385642 [TBL] [Abstract][Full Text] [Related]
90. Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1999 Jan; 48(RR-1):1-21. PubMed ID: 10077411 [TBL] [Abstract][Full Text] [Related]
92. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):374-5. PubMed ID: 19373199 [TBL] [Abstract][Full Text] [Related]
93. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]
94. New vaccine approved for 2 hepatitis viruses. AIDS Read; 2001 Jun; 11(6):298. PubMed ID: 11449920 [No Abstract] [Full Text] [Related]
95. [Prevalence of anti-HAV antibodies in Warsaw population]. Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499 [TBL] [Abstract][Full Text] [Related]
96. An Advisory Committee Statement (ACS). Update on hepatitis A vaccine (Avaxim, Aventis Pasteur). National Advisory Committee on Immunisation (NACI) Can Commun Dis Rep; 2001 Oct; 27():1-2. PubMed ID: 11706685 [No Abstract] [Full Text] [Related]
97. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination. Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P; J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475 [No Abstract] [Full Text] [Related]
98. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents. Siberry GK; Coller RJ; Henkle E; Kiefner C; Joyner M; Rogers J; Chang J; Hutton N Pediatr Infect Dis J; 2008 May; 27(5):465-8. PubMed ID: 18382387 [TBL] [Abstract][Full Text] [Related]
99. New developments in hepatitis A control. Yuan L Can Fam Physician; 1995 Jul; 41():1199-205. PubMed ID: 7647625 [TBL] [Abstract][Full Text] [Related]
100. The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States-Mexico Border. Ernst KC; Erhart LM Hum Vaccin Immunother; 2014; 10(5):1396-403. PubMed ID: 24603091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]